ERBB2 and breast cancer: In diseases such as cancer, some membrane receptors change their normal activity levels, for instance, overexpression of human epidermal growth factor receptor 2 (Her2) in breast cancer [61] and Mesothelin in malignant pleural mesothelioma [62].